Eton Pharmaceuticals Inc. (ETON) on Thursday said it has appointed Judith M. Matthews as Executive Vice President, Accounting and Finance, effective immediately.
Matthews will assume the role of Chief Financial Officer on June 1, 2026, succeeding James Gruber, who will step down as part of a planned succession.
Matthews brings more than 25 years of finance leadership experience and previously served as Chief Financial Officer at Iterum Therapeutics plc from 2015 to 2026.
On Wednesday, Eton shares closed at $26.97, down 0.55%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.